Mazzaferro V - Search Results

1

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.

Geissler EK, Schnitzbauer AA, Zülke C, Lamby PE, Proneth A, Duvoux C, Burra P, Jauch KW, Rentsch M, Ganten TM, Schmidt J, Settmacher U, Heise M, Rossi G, Cillo U, Kneteman N, Adam R, van Hoek B, Bachellier P, Wolf P, Rostaing L, Bechstein WO, Rizell M, Powell J, Hidalgo E, Gugenheim J, Wolters H, Brockmann J, Roy A, Mutzbauer I, Schlitt A, Beckebaum S, Graeb C, Nadalin S, Valente U, Turrión VS, Jamieson N, Scholz T, Colledan M, Fändrich F, Becker T, Söderdahl G, Chazouillères O, Mäkisalo H, Pageaux GP, Steininger R, Soliman T, de Jong KP, Pirenne J, Margreiter R, Pratschke J, Pinna AD, Hauss J, Schreiber S, Strasser S, Klempnauer J, Troisi RI, Bhoori S, Lerut J, Bilbao I, Klein CG, Königsrainer A, Mirza DF, Otto G, Mazzaferro V, Neuhaus P, Schlitt HJ. Geissler EK, et al. Among authors: mazzaferro v. Transplantation. 2016 Jan;100(1):116-25. doi: 10.1097/TP.0000000000000965. Transplantation. 2016. PMID: 26555945 Free PMC article. Clinical Trial.

2

Reappraisal of the role of liver transplantation in the treatment of hepatocellular carcinoma arising in cirrhosis.

Gennari L, Mazzaferro V, Regalia E, Colella G, Doci R, Bozzetti F, Ammatuna M, Andreola S, Montalto F, Manzi R, et al. Gennari L, et al. Among authors: mazzaferro v. J Surg Oncol Suppl. 1993;3:83-6. doi: 10.1002/jso.2930530523. J Surg Oncol Suppl. 1993. PMID: 7684917

3

Milan multicenter experience in liver transplantation for hepatocellular carcinoma.

Mazzaferro V, Rondinara GF, Rossi G, Regalia E, De Carlis L, Caccamo L, Doci R, Sansalone CV, Belli LS, Armiraglio E, et al. Mazzaferro V, et al. Transplant Proc. 1994 Dec;26(6):3557-60. Transplant Proc. 1994. PMID: 7998274 Clinical Trial. No abstract available.

4

Orthotopic liver transplantation for primary biliary tumors: Milan multicenter experience.

Sansalone CV, Colella G, Caccamo L, Rondinara GF, Fassati LR, Rossetti O, De Carlis L, Galmarini D, Aseni P, Mazzaferro V, et al. Sansalone CV, et al. Among authors: mazzaferro v. Transplant Proc. 1994 Dec;26(6):3561-3. Transplant Proc. 1994. PMID: 7998275 Clinical Trial. No abstract available.

5

Pattern of recurrence of hepatocellular carcinoma after liver transplantation: Milan multicenter experience.

Regalia E, Sansalone C, Mazzaferro V, Reggiani P, Rondinara GF, Lucianetti A, Pulvirenti A, De Carlis L, Paone G, Belli L, et al. Regalia E, et al. Among authors: mazzaferro v. Transplant Proc. 1994 Dec;26(6):3579-80. Transplant Proc. 1994. PMID: 7998280 Clinical Trial. No abstract available.

6

Milan multicenter experience in liver transplantation for hepatitis C-related cirrhosis: report of 105 cases.

Belli LS, Caccamo L, Mazzaferro V, Silini E, Alberti A, Melada E, Regalia E, Gridelli B, Rubino A, Gennari L, et al. Belli LS, et al. Among authors: mazzaferro v. Transplant Proc. 1994 Dec;26(6):3582-4. Transplant Proc. 1994. PMID: 7998282 Clinical Trial. No abstract available.

7

Milan multicenter experience in 96 liver transplants for hepatitis B virus-related cirrhosis.

Caccamo L, Belli LS, Mazzaferro V, Colledan M, Alberti A, Regalia E, Fassati LR, Ideo G, Rubino A, Belli L, et al. Caccamo L, et al. Among authors: mazzaferro v. Transplant Proc. 1994 Dec;26(6):3585-7. Transplant Proc. 1994. PMID: 7998283 Clinical Trial. No abstract available.

8

Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing.

Mazzaferro V, Andreola S, Regalia E, Poli F, Doci R, Bozzetti F, Gennari L. Mazzaferro V, et al. Transplantation. 1993 Feb;55(2):423-5. Transplantation. 1993. PMID: 8434393 No abstract available.

9

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Mazzaferro V, et al. N Engl J Med. 1996 Mar 14;334(11):693-9. doi: 10.1056/NEJM199603143341104. N Engl J Med. 1996. PMID: 8594428 Free article.

10

Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence. The European Cooperative Study Group on Liver Cancer and Transplantation.

Mazzaferro V, Regalia E, Montalto F, Pulvirenti A, Brunetto MR, Bonino F, Lerut J, Gennari L. Mazzaferro V, et al. Liver. 1996 Apr;16(2):117-22. doi: 10.1111/j.1600-0676.1996.tb00715.x. Liver. 1996. PMID: 8740845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page